Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- AARTIPHARM.NSE
- Price
- 686.25
- Stock movement up
- +13.10 (1.91%)
- Company name
- Aarti Pharmalabs Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 63.38B
- Ent value
- 72.17B
- Price/Sales
- 3.22
- Price/Book
- 3.41
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 27.79
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 38.64%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-01-02
DIVIDENDS
AARTIPHARM.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 27.79 |
| Price to OCF | 168.83 |
| Price to FCF | 168.83 |
| Price to EBITDA | 65.29 |
| EV to EBITDA | 74.35 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.22 |
| Price to Book | 3.41 |
| EV to Sales | 3.67 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 90.63M |
| EPS (TTM) | 25.14 |
| FCF per share (TTM) | 4.14 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 19.68B |
| Gross profit (TTM) | 7.22B |
| Operating income (TTM) | 3.26B |
| Net income (TTM) | 2.28B |
| EPS (TTM) | 25.14 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 36.69% |
| Operating margin (TTM) | 16.55% |
| Profit margin (TTM) | 11.59% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 408.08M |
| Net receivables | 4.34B |
| Total current assets | 13.77B |
| Goodwill | 17.81M |
| Intangible assets | 899.60M |
| Property, plant and equipment | 0.00 |
| Total assets | 27.77B |
| Accounts payable | 3.34B |
| Short/Current long term debt | 3.86B |
| Total current liabilities | 6.83B |
| Total liabilities | 9.20B |
| Shareholder's equity | 18.57B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 375.40M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 375.40M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 12.28% |
| Return on Assets | 8.21% |
| Return on Invested Capital | 10.71% |
| Cash Return on Invested Capital | 1.76% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 679.10 |
| Daily high | 719.80 |
| Daily low | 679.10 |
| Daily Volume | 799K |
| All-time high | 699.50 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | 25.14 |
| Dividend per share | - |
| Ex-div date | 31 Jul 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AARTIPHARM.NSE | S&P500 | |
| Current price drop from All-time high | -1.89% | -3.58% |
| Highest price drop | -25.29% | -56.47% |
| Date of highest drop | 13 Mar 2024 | 9 Mar 2009 |
| Avg drop from high | -8.30% | -11.12% |
| Avg time to new high | 13 days | 12 days |
| Max time to new high | 87 days | 1805 days |
COMPANY DETAILS
Marketcap
63.38B
Marketcap category
Large-cap
Description
Aarti Pharmalabs Limited, together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system (CNS) agents, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acidic and allied products comprising sulphuric acid, sulphur trioxide, oleum, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.
Employees
2095
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found